Asston Pharmaceuticals
add_icon

Asston Pharmaceuticals

109.00
+2.00
(1.87%)
Market Cap
119.09 Cr
PE Ratio
-
Volume
2,000.00
Day High - Low
109.00 - 104.00
52W High-Low
126.10 - 60.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
119.09 Cr
EPS
4.92
PE Ratio
-
PB Ratio
-
Book Value
60.96
EBITDA
-0.56
Dividend Yield
0.00 %
Return on Equity
34.91
Debt to Equity
0.77
Forecast For
Actual

Company News

View All News
Caret
positive
Asston Pharmaceuticals Ltd approved the allotment of 24,10,431 equity shares at ₹115 per share to 15 investors. The move increases paid-up capital to ₹10.92 crore.
neutral
Asston Pharmaceuticals Ltd board meeting on Sep 4, 2026 approved new statutory and internal auditors, re-appointed MD Ashish Sakalkar, and increased remuneration for three directors. The 7th AGM is scheduled for Sep 29, 2026.
neutral
Prakruti R Pali acquired 2,40,000 shares of Asston Pharmaceuticals Ltd on August 27, 2026, via open market. The stake rose from 2.51% to 5.33%, with no encumbrances reported.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,625.00
#1 75,508.48
18.29
#1 26,536.80
78.75
#1 3,858
15.40
47.34
17,500.00
70,304.91
61.29
22,966.90
22.95
977
77.82
57.03
974.20
44,130.71
26.31
7,824.37
17.62
1,483
53.31
39.01
346.00
23,955.14
18.63
5,049.88
#1 113.95
1,139
102.61
65.40
2,264.50
15,124.07
111.42
1,632.10
46.35
113
#1 145.77
57.40
323.10
9,830.08
#1 15.23
4,821.20
90.97
565
43.19
46.80
166.86
6,046.25
16.80
4,861.90
40.86
469
-85.16
44.22
395.95
5,032.72
20.77
4,548.44
107.45
350
-95.45
33.42
532.40
4,969.90
39.20
5,195.10
40.61
109
121.38
55.83
4,174.40
4,775.60
34.52
678.00
6.00
158
-49.64
52.64
Growth Rate
Revenue Growth
-0.51 %
Net Income Growth
1.79 %
Cash Flow Change
99.24 %
ROE
64.05 %
ROCE
32.28 %
EBITDA Margin (Avg.)
-107.55 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
2026
TTM
Revenue
11
7
16
26
25
0
Expenses
10
5
13
20
26
0
EBITDA
1
2
3
6
-1
0
Operating Profit %
-4 %
23 %
16 %
22 %
-2 %
0 %
Depreciation
0
0
0
0
0
0
Interest
0
1
1
1
1
0
Profit Before Tax
0
1
2
5
5
0
Tax
0
0
1
1
1
0
Net Profit
0
1
1
4
4
0
EPS in ₹
11.62
1.89
2.37
6.14
4.92
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
2026
Total Assets
10
14
20
28
52
Fixed Assets
1
1
1
1
11
Current Assets
7
11
18
27
41
Capital Work in Progress
0
0
0
0
0
Investments
0
0
0
0
1
Other Assets
9
13
19
27
0
Total Equity & Liabilities
10
14
20
28
52
Current Liabilities
8
10
12
15
9
Non Current Liabilities
1
2
2
2
4
Total Equity
1
2
6
11
39
Reserve & Surplus
0
1
6
5
30
Share Capital
1
1
1
6
9

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
0
-0
0
Investing Activities
0
-1
0
1
Operating Activities
-1
-0
-4
0
Financing Activities
1
1
4
-1

Share Holding

% Holding
Jan 2025
Jun 2025
Jul 2025
Sept 2025
Mar 2026
Promoter
69.07 %
50.66 %
68.76 %
50.66 %
50.66 %
FIIs
0.00 %
9.70 %
0.00 %
6.04 %
1.91 %
DIIs
0.00 %
4.08 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
30.95 %
0.00 %
37.06 %
40.53 %
Others
30.93 %
4.61 %
31.24 %
6.24 %
6.90 %
No of Share Holders
104
662
128
751
687

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2026 105.65 109.00
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 102.45 96.13
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 77.10 77.60
28 Apr 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
28 Apr 2026 70.38 77.22
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 72.67 73.01
31 Jul 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Jul 2026 80.00 67.40

Announcements

Reg. 34 (1) Annual Report.5 days ago
Notice Of 7Th Annual General Meeting5 days ago
Announcement under Regulation 30 (LODR)-Allotment7 days ago
Board Meeting Outcome for Allotment Of 2410431 Equity Shares Via Preferential Allotment7 days ago
Fixing Record Date8 days ago
Fixing 29Th September 2026 As The Date For Convening The 7Th Annual General Meeting Of The Company.8 days ago
Announcement under Regulation 30 (LODR)-Meeting Updates8 days ago
Announcement under Regulation 30 (LODR)-Change in Management8 days ago
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s8 days ago
Board Meeting Outcome for Out Come Of The Board Meeting8 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20118 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 201110 days ago
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 01, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Aug 31, 2026
Board Meeting Intimation for Convening 7Th Annual General Meeting Of The CompanyAug 27, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 03, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMJul 31, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 10, 2026
Notice Of Second Extraordinary General Meeting For F.Y. 2026-27 Scheduled To Be Held On 31St July 2026 At 12:30 PMJul 09, 2026
Announcement under Regulation 30 (LODR)-Meeting UpdatesJul 02, 2026
Announcement Regarding Extraordinary General Meeting Of The Company.Jul 02, 2026
Update On Board Meeting Scheduled To Be Held On 02Nd July 2026.Jul 02, 2026
Announcement under Regulation 30 (LODR)-Preferential IssueJul 02, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Scheduled To Be Held On 02Nd July 2026.Jul 02, 2026
Closure of Trading WindowJun 24, 2026
Board Meeting Intimation for Board Meeting IntimationJun 24, 2026
Audited Financial Results For The Financial Year Ended 31St March 2026.May 29, 2026
Audited Financial Results For The Financial Year Ended 31St March 2026.May 29, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th May 2026May 29, 2026
Board Meeting Intimation for Approving Audited Financial RessultsMay 21, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 28, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMApr 28, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 21, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Record DateApr 06, 2026
Notice Of Extraordinary General MeetingApr 06, 2026
The Extraordinary General Meeting Is Scheduled On Tuesday 28Th April 2026.Mar 30, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 30, 2026
Announcement under Regulation 30 (LODR)-Meeting UpdatesMar 30, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Schedule To Be Held On 30Th March 2026Mar 30, 2026
Closure of Trading WindowMar 26, 2026
Board Meeting Intimation for Scheduled To Be Held On 30Th March 2026 At 3:00 P.M. At The Registered Office Of The CompanyMar 25, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 02, 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMar 02, 2026
Cancellation of Board MeetingFeb 07, 2026
Closure of Trading WindowJan 30, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 29, 2026
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsJan 29, 2026

Technical Indicators

RSI(14)
Neutral
60.62
ATR(14)
Less Volatile
7.11
STOCH(9,6)
Neutral
44.30
STOCH RSI(14)
Oversold
12.37
MACD(12,26)
Bearish
-0.44
ADX(14)
Strong Trend
40.49
UO(9)
Bearish
58.15
ROC(12)
Uptrend And Accelerating
13.48
WillR(14)
Neutral
-37.92